These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6271423)

  • 1. Serum apoprotein A-I and A-II levels in liver diseases and cholestasis.
    Fujii S; Koga S; Shono T; Yamamoto K; Ibayashi H
    Clin Chim Acta; 1981 Sep; 115(3):321-31. PubMed ID: 6271423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoassay of alpha-fetoprotein. II. Studies in patients suffering from hepatic diseases.
    Delmont J; Kermarec J; Lafon J; Bonet C; Cassuto JP; Masseyeff R
    Digestion; 1974; 10(1):29-39. PubMed ID: 4136258
    [No Abstract]   [Full Text] [Related]  

  • 3. High-density lipoprotein cholesterol and phospholipids, and apoprotein A in serum of patients with liver disease.
    Rubiés-Prat J; Masdeu S; Nubiola AR; Chacón P; Holguera C; Masana L
    Clin Chem; 1982 Mar; 28(3):525-7. PubMed ID: 7067098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An abnormal low density lipoprotein in cholestaris. II. Significance for the differential diagnosis of jaundice].
    Seidel D; Schmitt EA; Alaupovic P
    Dtsch Med Wochenschr; 1970 Sep; 95(36):1805-9. PubMed ID: 5465694
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum apolipoproteins A-I, A-II and B in hepatic metastases. Comparison with other liver diseases: hepatomas and cirrhosis.
    Hachem H; Favre G; Raynal G; Blavy G; Canal P; Soula G
    J Clin Chem Clin Biochem; 1986 Mar; 24(3):161-6. PubMed ID: 2872262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of serum levels of tryptophan in hepatobiliary disease.
    Yoshida K; Hirayama C
    Clin Chim Acta; 1980 Feb; 101(2-3):235-40. PubMed ID: 6244122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum squalene levels in hepatobiliary diseases.
    Yamanishi Y; Ikawa S; Hirayama C
    Clin Chim Acta; 1978 Aug; 88(1):105-10. PubMed ID: 679482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Summary of a systemic search for alpha-1-feto-protein in 224 hepatic diseases].
    Geffroy Y; Boureille J; Denis P; Colin R; Métayer P
    Sem Hop; 1971 Apr; 47(20):1281-5. PubMed ID: 4326656
    [No Abstract]   [Full Text] [Related]  

  • 9. [Summary of a systematic search for alpha-1-feto-protein in 224 hepatic diseases].
    Geffroy Y; Boureille J; Denis P; Colin R; Métayer P
    Sem Hop; 1971 Apr; 47(20):1281-5. PubMed ID: 4326531
    [No Abstract]   [Full Text] [Related]  

  • 10. Apolipoproteins A-I, A-II and B in chronic active hepatitis and in liver cirrhotic patients.
    Cordova C; Musca A; Violi F; Alessandri C; Iuliano L
    Clin Chim Acta; 1984 Feb; 137(1):61-6. PubMed ID: 6421513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative determination of non-sulfated bile acids in the serum of patients with hepatobiliary diseases by mass fragmentography.
    Takikawa H; Beppu T; Seyama Y; Wada T
    Gastroenterol Jpn; 1983 Jun; 18(3):246-51. PubMed ID: 6307803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection and determination of alpha-feto-protein in human serum. Use in hepato-gastroenterology].
    Borel-Giraud N; Berthet P; Nyssen M; Dorche J; Girard M; Bel A; Vachon A; Plauchu A; Saint Cyr M
    Nouv Presse Med; 1975 Jan; 4(1):27-30. PubMed ID: 49879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endotoxin in severe liver diseases (author's transl)].
    Iwasaki M; Maruyama I; Ikeziri N; Abe M; Maeyama T; Nagata E; Abe H; Tanikawa K
    Nihon Shokakibyo Gakkai Zasshi; 1980 Mar; 77(3):386-94. PubMed ID: 6247524
    [No Abstract]   [Full Text] [Related]  

  • 14. [Behavior of total lipids, cholesterol, lipoproteins and apolipoprotein A in the blood of subjects with acute hepatitis and chronic hepatopathy].
    Vergani C; Trovato G; Pietrogrande M; Crocchiolo P; Dioguardi N
    Minerva Med; 1978 Jun; 69(31):2081-94. PubMed ID: 208025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum desialylated glycoproteins in patients with hepatobiliary dysfunction.
    Marshall JS; Williams S; Jones P; Hepner GW
    J Lab Clin Med; 1978 Jul; 92(1):30-7. PubMed ID: 96195
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical significance of serum glutathione reductase in various clinical conditions, especially in liver diseases.
    Wakui K; Kumata H; Tadaki H; Yamagata S
    Tohoku J Exp Med; 1976 Jan; 118(1):17-23. PubMed ID: 1251442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic secretion enzymes and electrophoretic lipoprotein fractions in liver disease.
    Tăpălagă D; Opincaru A; Cucuianu M
    Acta Hepatogastroenterol (Stuttg); 1979 Feb; 26(1):9-16. PubMed ID: 34311
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bile acids in the serum of patients with extrahepatic cholestasis with chronic liver diseases].
    Erb W; Schreiber J; Walczak M
    Z Gastroenterol; 1973 May; 11(4):279-88. PubMed ID: 4803425
    [No Abstract]   [Full Text] [Related]  

  • 19. [Significance of the uranyl acetate test in the diagnosis of liver diseases].
    Fischer P; Reinelt D
    Z Gesamte Inn Med; 1968 Jun; 23(12):Suppl:177-9. PubMed ID: 5687435
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum-alpha 1-fetoprotein in hepatocellular carcinoma.
    Kohn J; Weaver PC
    Lancet; 1974 Aug; 2(7876):334-6. PubMed ID: 4136060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.